This statistic depicts the distribution of European clinical and phase III pipeline in 2013, by indication. Among all products in the clinical pipeline, some 31 percent were products concerning cancer. In the phase III pipeline, some 27 percent of products were for cancer.
Distribution of European clinical and phase III pipeline in 2013, by indication
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
EY. (June 23, 2014). Distribution of European clinical and phase III pipeline in 2013, by indication [Graph]. In Statista. Retrieved December 21, 2024, from https://www.statista.com/statistics/262670/distribution-of-us-clinical-and-phase-iii-pipeline-by-indication/
EY. "Distribution of European clinical and phase III pipeline in 2013, by indication." Chart. June 23, 2014. Statista. Accessed December 21, 2024. https://www.statista.com/statistics/262670/distribution-of-us-clinical-and-phase-iii-pipeline-by-indication/
EY. (2014). Distribution of European clinical and phase III pipeline in 2013, by indication. Statista. Statista Inc.. Accessed: December 21, 2024. https://www.statista.com/statistics/262670/distribution-of-us-clinical-and-phase-iii-pipeline-by-indication/
EY. "Distribution of European Clinical and Phase Iii Pipeline in 2013, by Indication." Statista, Statista Inc., 23 Jun 2014, https://www.statista.com/statistics/262670/distribution-of-us-clinical-and-phase-iii-pipeline-by-indication/
EY, Distribution of European clinical and phase III pipeline in 2013, by indication Statista, https://www.statista.com/statistics/262670/distribution-of-us-clinical-and-phase-iii-pipeline-by-indication/ (last visited December 21, 2024)
Distribution of European clinical and phase III pipeline in 2013, by indication [Graph], EY, June 23, 2014. [Online]. Available: https://www.statista.com/statistics/262670/distribution-of-us-clinical-and-phase-iii-pipeline-by-indication/
